RAPID DOSE THERAPEUTICS CORP. Rapid Dose Therapeutics Corp. Share Price
Equities
DOSE
CA75339A1012
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.255 CAD | +2.00% |
|
+24.39% | +54.55% |
| 03-25 | Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding | CI |
| 02-08 | Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors | CI |
| Sales 2022 | 1.75 2.39 140.28 | Sales 2023 | 0.72 0.98 57.51 | Capitalization | 9.32M 12.73M 746M |
|---|---|---|---|---|---|
| Net income 2022 | -8M -10.93M -641M | Net income 2023 | -3M -4.1M -240M | EV / Sales 2022 | 15,898,275 x |
| Net Debt 2022 | 1.4M 1.91M 112M | Net Debt 2023 | 2.1M 2.86M 168M | EV / Sales 2023 | 15,894,851 x |
| P/E ratio 2022 |
-3.01
x | P/E ratio 2023 |
-2.44
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.12% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +2.00% | ||
| 1 week | +24.39% | ||
| Current month | +41.67% | ||
| 1 month | +50.00% | ||
| 3 months | +59.38% | ||
| 6 months | +13.33% | ||
| Current year | +54.55% |
1 week
0.18
0.28
1 month
0.180.28
Current year
0.100.28
1 year
0.090.28
3 years
0.070.70
5 years
0.000.98
10 years
0.001.33
| Managers | Title | Age | Since |
|---|---|---|---|
Mark Upsdell
CEO | Chief Executive Officer | - | 02/05/17 |
Doug Hyland
DFI | Director of Finance/CFO | - | 27/02/20 |
| Corporate Officer/Principal | - | 22/01/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Donald Sheldon
LAW | General Counsel | 77 | 05/12/19 |
John McKimm
BRD | Director/Board Member | - | 13/04/23 |
| Director/Board Member | - | 12/08/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.255 | +2.00% | 81,000 |
| 25/04/24 | 0.25 | 0.00% | 107,970 |
| 24/04/24 | 0.25 | +13.64% | 36,000 |
| 23/04/24 | 0.22 | +4.76% | 222,585 |
| 22/04/24 | 0.21 | +2.44% | 5,000 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 03:38 pm
More quotes
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. The Company provides disruptive drug delivery technologies designed to improve patient outcomes. The Companyâs flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product. The Company also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries.
Calendar
29/07/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +54.55% | 22.5M | |
| -10.84% | 187M | |
| -59.36% | 82M |
- Stock Market
- Equities
- DOSE Stock
